2019 marked the 15th consecutive year that VACFA has conducted the Annual African Vaccinology Course (AAVC). Participants from 23 African countries were in attendance during the course
23 Countries were represented at the 2019 AAVC
The course was convened by Prof. Gregory Hussey, Dr Benjamin Kagina and A/Prof Rudzani Muloiwa A diverse pool of 40 (local and international) faculty members gave talks at the course. The faculty members were from academic institutions, not for profit organizations, industry sectors and the media.
Aims of the 15th AAVC
Provide participants with essential expertise to support national immunisation programmes
Broaden the understanding of the challenges and opportunities in vaccinology at regional and global levels
Build sustainable research capacity for vaccine development and conducting high quality phase I-IV vaccine trials in Africa
Foster communication and networking among African vaccinologists
Discuss the feasibility of vaccinology e-learning in Africa
Discuss the roles and challenges of the National Immunisation Technical Advisory Groups (NITAGs) in the strengthening of the immunisation programmes in Africa
There were many highlights during the 2019 course:
Sharing of the experiences gained during the response to Ebola and measles outbreak in the DRC
Sharing of the recent data on malaria vaccine trials in Africa
Developments in the field of maternal immunisation
Application of design thinking to address challenges facing immunisation challenges in Africa
Participants indicated the critical use of the online pre-course reading that was aimed at priming them with basic vaccinology knowledge prior to the 5-day face to face training. The online pre-course reading is a partnership between VACFA and Immunopaedia. The partnership started in 2017.
A NITAG workshop was held on the 8 November in the afternoon. Members from 4 African countries participated in the workshop. Discussions were held on how VACFA, together with other stakeholders, can work together to provide technical/scientific support to NITAGs in Africa
With the exception of a few participants from the sponsors, all participants attending the 15th AAVC were fully funded through grants obtained by VACFA from the following sponsors: GSK, Merck, Pfizer, Sanofi Pasteur and the University of Cape Town (UCT).
Page created on 24 April 2019
Page updated on 29 April 2020
The Vaccine Safety Net is a global network of websites, evaluated by the World Health Organization, that provide reliable information on vaccine safety.
Vaccines for Africa Initiative (VACFA)
Institute of Infectious Diseases and Molecular Medicine (IDM)
Wernher & Beit North Wing, Room N2.09A
University of Cape Town
Faculty of Health Sciences
Observatory, 7925, Cape Town, South Africa